Fatal sepsis in a patient with rheumatoid arthritis treated with etanercept.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 11393506.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Patients with long-standing, severe, erosive rheumatoid arthritis who have extra-articular manifestations and have undergone joint replacement surgery are at increased risk for serious infection and premature mortality. New therapies, including cytokine antagonists, hold great promise for improving the course of rheumatoid arthritis. However, they have powerful anti-inflammatory effects that may mask symptoms of serious infection. We report a case of fatal pneumococcal sepsis occurring in a 37-year-old woman with rheumatoid arthritis treated with the tumor necrosis factor antagonist etanercept and suggest management strategies for early detection and management of this complication.
Medical subject headings
- Antirheumatic Agents
- Arthritis, Infectious
- Arthritis, Rheumatoid
- Bacteremia
- Fasciitis, Necrotizing
- Immunoglobulin G
- Pneumococcal Infections
- Streptococcus pneumoniae
- Tumor Necrosis Factor-alpha